CSF2 and central nervous system cancer: Besides IGF-1/PI3K signaling, several glioma cell-derived factors, such as GM-CSF and IFN-γ, seem to protect GAMs from CSF-1R inhibitor-mediated depletion and thereby mediate therapy resistance [97].